These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7511303)

  • 1. [Pathology of prostatic carcinoma: new approaches to its development and biological significance].
    Kastendieck H
    Verh Dtsch Ges Pathol; 1993; 77():40-69. PubMed ID: 7511303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.
    Noguchi M; Stamey TA; Neal JE; Yemoto CE
    J Urol; 2000 Jun; 163(6):1751-5. PubMed ID: 10799175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features.
    Cohen RJ; Shannon BA; Phillips M; Moorin RE; Wheeler TM; Garrett KL
    J Urol; 2008 May; 179(5):1762-7; discussion 1767. PubMed ID: 18343454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
    Helpap B; Bonkhoff H; Cockett A; Montironi R; Troncoso P; Waters D; Bostwick D
    Pathologica; 1997 Jun; 89(3):288-300. PubMed ID: 9270265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suspicious acinar proliferations of the prostate].
    Helpap B
    Verh Dtsch Ges Pathol; 1999; 83():162-7. PubMed ID: 10714207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
    Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
    Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.
    Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO
    Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic urothelial location of a tumor of the bladder].
    Coulange C; Lechevallier E; de Fromont M
    Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostate gland-transition zone lesions. Etiology, growth regulation, growth factors, genetic changes].
    Pavelić J; Zeljko Z
    Lijec Vjesn; 2002; 124(6-7):211-9. PubMed ID: 19658339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
    Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
    Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Garcia FU; Haber MM; Chen X
    Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.